XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock and paid-in capital
Common stock and paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated deficit
Accumulated deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Balance, beginning of period at Dec. 31, 2020   $ 534,745   $ (51,186)   $ 434
Issuance of common stock from exercise of equity awards and employee stock purchase plan   3,684        
Payment of withholding taxes related to net share settlement of equity awards   (20,311)        
Equity component of convertible senior notes, net   207,970        
Cost of convertible notes hedge related to the convertible senior notes, net   (213,322)        
Sale of warrants related to the convertible senior notes   220,800        
Equity component of settlement of convertible senior notes, net   (966,557)        
Settlement of convertible senior notes   962,176        
Stock-based compensation   77,110        
Net income $ 92,858     92,858    
Repurchase of common stock       (200,000)    
Foreign currency translation adjustments (302)         (302)
Change in net unrealized loss on marketable securities, net of tax (284)         (284)
Balance, end of period at Sep. 30, 2021 $ 647,815 806,295   (158,328)   (152)
Balance, beginning of period at Dec. 31, 2020   534,745   (51,186)   434
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06          
Balance, end of period at Dec. 31, 2021 $ 430,168 837,925 $ (207,967) (405,737) $ 25,710 (2,020)
Balance, beginning of period at Jun. 30, 2021   762,612   (180,137)   1,924
Issuance of common stock from exercise of equity awards and employee stock purchase plan   42        
Payment of withholding taxes related to net share settlement of equity awards   (3,313)        
Stock-based compensation   46,954        
Net income 21,809     21,809    
Foreign currency translation adjustments (1,792)         (1,792)
Change in net unrealized loss on marketable securities, net of tax (284)         (284)
Balance, end of period at Sep. 30, 2021 647,815 806,295   (158,328)   (152)
Balance, beginning of period at Dec. 31, 2021 430,168 837,925 $ (207,967) (405,737) $ 25,710 (2,020)
Issuance of common stock from exercise of equity awards and employee stock purchase plan   5,280        
Payment of withholding taxes related to net share settlement of equity awards   (19,396)        
Stock-based compensation   146,171        
Net income 243,609     243,609    
Foreign currency translation adjustments (5,670)         (5,670)
Change in net unrealized loss on marketable securities, net of tax (7,852)         (7,852)
Balance, end of period at Sep. 30, 2022 610,053 762,013   (136,418)   (15,542)
Balance, beginning of period at Jun. 30, 2022   713,474   (251,230)   (11,245)
Issuance of common stock from exercise of equity awards and employee stock purchase plan   693        
Payment of withholding taxes related to net share settlement of equity awards   (4,589)        
Stock-based compensation   52,435        
Net income 114,812     114,812    
Foreign currency translation adjustments (3,364)         (3,364)
Change in net unrealized loss on marketable securities, net of tax (933)         (933)
Balance, end of period at Sep. 30, 2022 $ 610,053 $ 762,013   $ (136,418)   $ (15,542)